Mitochondrial dysfunction and mitophagy: The beginning and end to diabetic nephropathy?

British Journal of Pharmacology

Volumn 171, Issue 8, 2014, Pages 1917-1942

  Higgins, G C ^a,b   Coughlan, M T ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

autophagy; diabetes; diabetic nephropathy; dynamics; kidney; mitochondria; mitochondrial dysfunction; mitophagy

Indexed keywords

ADAPTOR PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; RILMENIDINE; ANTIOXIDANT;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; DIABETIC NEPHROPATHY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; DYNAMICS; END STAGE RENAL DISEASE; HUMAN; HYPERGLYCEMIA; KIDNEY FIBROSIS; KIDNEY INJURY; MICROALBUMINURIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOPHAGY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; DIABETIC NEPHROPATHIES; DRUG EFFECTS; FIBROSIS; MITOCHONDRIAL DISEASES; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; AUTOPHAGY; CELL DEATH; DIABETIC NEPHROPATHIES; FIBROSIS; HUMANS; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY;

EID: 84897380527     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12503     Document Type: Review

References (321)

1. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986.
2. American Diabetes Association (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36: 1033-1046.
3. Andrabi SA, Dawson TM, Dawson VL, (2008). Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci 1147: 233-241.
4. Armstrong JS, (2006). The role of the mitochondrial permeability transition in cell death. Mitochondrion 6: 225-234.
5. Atkinson SJ, Hosford MA, Molitoris BA, (2004). Mechanism of actin polymerization in cellular ATP depletion. J Biol Chem 279: 5194-5199.
6. Baines CP, (2010). Role of the mitochondrion in programmed necrosis. Front Physiol 1: 156.
7. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662.
8. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD, (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555.
9. Balaban RS, Mandel LJ, (1988). Metabolic substrate utilization by rabbit proximal tubule. An NADH fluorescence study. Am J Physiol 254 (3 Pt 2): F407-F416.
10. Barbosa Junior Ade A, Zhou H, Hultenschmidt D, Totovic V, Jurilj N, Pfeifer U, (1992). Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol 61: 359-366.
11. Baynes JW, (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
12. Baynes JW, Thorpe SR, (1999). Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
13. Bechtel W, Helmstadter M, Balica J, Hartleben B, Kiefer B, Hrnjic F, et al. (2013). Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol 24: 727-743.
14. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, et al. (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581.
15. Benfeito S, Oliveira C, Soares P, Fernandes C, Silva T, Teixeira J, et al. (2013). Antioxidant therapy: still in search of the 'magic bullet'. Mitochondrion 13: 427-435.
16. Bensaad K, Cheung EC, Vousden KH, (2009). Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 28: 3015-3026.
17. Bernardi P, (2013). The mitochondrial permeability transition pore: a mystery solved? Front Physiol 4: 95.
18. Betin VM, Lane JD, (2009). Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci 122 (Pt 14): 2554-2566.
19. Betin VM, MacVicar TD, Parsons SF, Anstee DJ, Lane JD, (2012). A cryptic mitochondrial targeting motif in Atg4D links caspase cleavage with mitochondrial import and oxidative stress. Autophagy 8: 664-676.
20. Bilous R, Chaturvedi N, Sjolie AK, Fuller J, Klein R, Orchard T, et al. (2009). Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med 151: 11-20, W13-W14.
21. Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24: 1250-1261.
22. Bizat N, Galas MC, Jacquard C, Boyer F, Hermel JM, Schiffmann SN, et al. (2005). Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology 49: 695-702.
23. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, et al. (2005). p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614.
24. de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, et al. (2011). Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171: 412-420.
25. Bonventre JV, Weinberg JM, (2003). Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210.
26. Boor P, Ostendorf T, Floege J, (2010). Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656.
27. Borch-Johnsen K, Kreiner S, (1987). Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 294: 1651-1654.
28. Brenner BM, Rector FC, (2008). Brenner & Rector's the Kidney. Elsevier/Saunders: Philadelphia, PA.
29. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869.
30. Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, et al. (1998). Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 53: 754-761.
31. Brooks C, Wei Q, Cho SG, Dong Z, (2009). Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119: 1275-1285.
32. Brownlee M, (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
33. Brownlee M, (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
34. Bugger H, Chen D, Riehle C, Soto J, Theobald HA, Hu XX, et al. (2009). Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes 58: 1986-1997.
35. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, et al. (2004). The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: 9103-9108.
36. Casalena G, Daehn I, Bottinger E, (2012). Transforming growth factor-beta, bioenergetics, and mitochondria in renal disease. Semin Nephrol 32: 295-303.
37. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, et al. (2008). Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14: 193-204.
38. de Cavanagh EM, Ferder L, Toblli JE, Piotrkowski B, Stella I, Fraga CG, et al. (2008). Renal mitochondrial impairment is attenuated by AT1 blockade in experimental type I diabetes. Am J Physiol Heart Circ Physiol 294: H456-H465.
39. Cebollero E, Reggiori F, Kraft C, (2012). Reticulophagy and ribophagy: regulated degradation of protein production factories. Int J Cell Biol 2012: 182834.
40. Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, et al. (2010). Prevention of diabetic nephropathy in Ins2(+/)(-)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 432: 9-19.
41. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, et al. (2011). Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20: 1726-1737.
42. Chavez-Valdez R, Martin LJ, Flock DL, Northington FJ, (2012). Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 219: 192-203.
43. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, et al. (1997). The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med 186: 1975-1983.
44. Chen G, Cizeau J, Vande Velde C, Park JH, Bozek G, Bolton J, et al. (1999). Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem 274: 7-10.
45. Chen Y, Dorn GW, 2nd, (2013). PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340: 471-475.
46. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB, (2007). Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci 120 (Pt 23): 4155-4166.
47. Chen Y, Lewis W, Diwan A, Cheng EH, Matkovich SJ, Dorn GW, 2nd, (2010). Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy. Proc Natl Acad Sci U S A 107: 9035-9042.
48. Cheung EC, Ludwig RL, Vousden KH, (2012). Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci U S A 109: 20491-20496.
49. Choi AM, Ryter SW, Levine B, (2013). Autophagy in human health and disease. N Engl J Med 368: 1845-1846.
50. Christofferson DE, Yuan J, (2010). Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22: 263-268.
51. Cina DP, Onay T, Paltoo A, Li C, Maezawa Y, De Arteaga J, et al. (2012a). Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 23: 412-420.
52. Cina DP, Onay T, Paltoo A, Li C, Maezawa Y, De Arteaga J, et al. (2012b). MTOR regulates autophagic flux in the glomerulus. Autophagy 8: 696-698.
53. Corcoran JB, McCarthy S, Griffin B, Gaffney A, Bhreathnach U, Borgeson E, et al. (2013). IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses. Biochim Biophys Acta 1833: 1969-1978.
54. Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, et al. (2007). Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 148: 886-895.
55. Coughlan MT, Mibus AL, Forbes JM, (2008). Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 1126: 190-193.
56. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, et al. (2009). RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 20: 742-752.
57. Crane FL, Hatefi Y, Lester RL, Widmer C, (1957). Isolation of a quinone from beef heart mitochondria. Biochim Biophys Acta 25: 220-221.
58. Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE, et al. (2012). Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 59: 446-452.
59. Cui M, Tang X, Christian WV, Yoon Y, Tieu K, (2010). Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 285: 11740-11752.
60. Davis RE, Williams M, (2012). Mitochondrial function and dysfunction: an update. J Pharmacol Exp Ther 342: 598-607.
61. De Duve C, Wattiaux R, (1966). Functions of lysosomes. Annu Rev Physiol 28: 435-492.
62. Dennis MD, Baum JI, Kimball SR, Jefferson LS, (2011). Mechanisms involved in the coordinate regulation of mTORC1 by insulin and amino acids. J Biol Chem 286: 8287-8296.
63. Ding WX, Ni HM, Li M, Liao Y, Chen X, Stolz DB, et al. (2010a). Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem 285: 27879-27890.
64. Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee SJ, et al. (2010b). TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem 285: 37909-37919.
65. Diwan A, Matkovich SJ, Yuan Q, Zhao W, Yatani A, Brown JH, et al. (2009). Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death. J Clin Invest 119: 203-212.
66. Du G, Jiao R, (2011). To prevent neurodegeneration: HDAC6 uses different strategies for different challenges. Commun Integr Biol 4: 139-142.
67. Duffield JS, (2010). Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30: 234-254.
68. Elgass K, Pakay J, Ryan MT, Palmer CS, (2013). Recent advances into the understanding of mitochondrial fission. Biochim Biophys Acta 1833: 150-161.
69. Elgendy M, Sheridan C, Brumatti G, Martin SJ, (2011). Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 42: 23-35.
70. Fang L, Xie D, Wu X, Cao H, Su W, Yang J, (2013a). Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells. PLoS ONE 8: e72344.
71. Fang L, Zhou Y, Cao H, Wen P, Jiang L, He W, et al. (2013b). Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia- induced podocyte injury. PLoS ONE 8: e60546.
72. Feng D, Liu L, Zhu Y, Chen Q, (2013). Molecular signaling toward mitophagy and its physiological significance. Exp Cell Res 319: 1697-1705.
73. Forbes JM, Cooper ME, (2013). Mechanisms of diabetic complications. Physiol Rev 93: 137-188.
74. Forbes JM, Coughlan MT, Cooper ME, (2008). Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454.
75. Foster KG, Fingar DC, (2010). Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285: 14071-14077.
76. National Kidney Foundation (2012). KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 60: 850-886.
77. Frank M, Duvezin-Caubet S, Koob S, Occhipinti A, Jagasia R, Petcherski A, et al. (2012). Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim Biophys Acta 1823: 2297-2310.
78. Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, et al. (2009). Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol 20: 1303-1313.
79. Galloway CA, Lee H, Nejjar S, Jhun BS, Yu T, Hsu W, et al. (2012). Transgenic control of mitochondrial fission induces mitochondrial uncoupling and relieves diabetic oxidative stress. Diabetes 61: 2093-2104.
80. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW, (2010). Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19: 4861-4870.
81. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131.
82. Giaime E, Yamaguchi H, Gautier CA, Kitada T, Shen J, (2012). Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening. PLoS ONE 7: e40501.
83. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, et al. (2005). Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16: 3736-3741.
84. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, et al. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110: 5887-5892.
85. Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, et al. (2011). Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121: 2197-2209.
86. Gomes LC, Scorrano L, (2008). High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochim Biophys Acta 1777: 860-866.
87. Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, et al. (2012). Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep 13: 378-385.
88. Ha H, Lee HB, (2005). Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 10 (Suppl.): S7-10.
89. Han K, Lehringer-Polzin M, Zhou H, Pfeifer U, (1992). Cellular autophagy in proximal tubules of early diabetic rats following insulin treatment and islet transplantation. Virchows Arch B Cell Pathol Incl Mol Pathol 61: 367-373.
90. Hanada T, Ohsumi Y, (2005). Structure-function relationship of Atg12, a ubiquitin-like modifier essential for autophagy. Autophagy 1: 110-118.
91. Hanna RA, Quinsay MN, Orogo AM, Giang K, Rikka S, Gustafsson AB, (2012). Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 287: 19094-19104.
92. Hansell P, Welch WJ, Blantz RC, Palm F, (2013). Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. Clin Exp Pharmacol Physiol 40: 123-137.
93. Hao LY, Giasson BI, Bonini NM, (2010). DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci U S A 107: 9747-9752.
94. Harman D, (1972). The biologic clock: the mitochondria? J Am Geriatr Soc 20: 145-147.
95. +-dependent adenosine triphosphatase-mediated ion transport in the intact renal cell. J Biol Chem 256: 10319-10328.
96. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395.
97. Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, et al. (2010). Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096.
98. Herzog C, Yang C, Holmes A, Kaushal GP, (2012). zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am J Physiol Renal Physiol 303: F1239-F1250.
99. Hickey FB, Corcoran JB, Docherty NG, Griffin B, Bhreathnach U, Furlong F, et al. (2011). IHG-1 promotes mitochondrial biogenesis by stabilizing PGC-1α. J Am Soc Nephrol 22: 1475-1485.
100. Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P, (2010). Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimers Dis 20 (Suppl. 2): S453-S473.
101. Higgins GC, Devenish RJ, Beart PM, Nagley P, (2011). Autophagic activity in cortical neurons under acute oxidative stress directly contributes to cell death. Cell Mol Life Sci 68: 3725-3740.
102. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. (2008). Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135: 1311-1323.
103. Hook SS, Orian A, Cowley SM, Eisenman RN, (2002). Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A 99: 13425-13430.
104. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, et al. (2004). Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328: 1105.
105. Hu P, Lai D, Lu P, Gao J, He H, (2012). ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int J Mol Med 29: 613-618.
106. Huang S, Yang ZJ, Yu C, Sinicrope FA, (2011). Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1. J Biol Chem 286: 40002-40012.
107. Huber TB, Edelstein CL, Hartleben B, Inoki K, Dong Z, Koya D, et al. (2012). Emerging role of autophagy in kidney function, diseases and aging. Autophagy 8: 1009-1031.
108. Iguchi M, Kujuro Y, Okatsu K, Koyano F, Kosako H, Kimura M, et al. (2013). Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J Biol Chem 288: 22019-22032.
109. Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, et al. (2011). mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 121: 2181-2196.
110. Ishihara M, Urushido M, Hamada K, Matsumoto T, Shimamura Y, Ogata K, et al. (2013). Sestrin2 and BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting protein3) regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am J Physiol Renal Physiol 305: F495-509.
111. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. (2010). p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591.
112. Jiang M, Wei Q, Dong G, Komatsu M, Su Y, Dong Z, (2012). Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 82: 1271-1283.
113. Jin SM, Youle RJ, (2012). PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 125 (Pt 4): 795-799.
114. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ, (2010). Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191: 933-942.
115. Johnston O, Rose CL, Webster AC, Gill JS, (2008). Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 19: 1411-1418.
116. Joselin AP, Hewitt SJ, Callaghan SM, Kim RH, Chung YH, Mak TW, et al. (2012). ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum Mol Genet 21: 4888-4903.
117. Junn E, Jang WH, Zhao X, Jeong BS, Mouradian MM, (2009). Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J Neurosci Res 87: 123-129.
118. Kaneda K, Iwao J, Sakata N, Takebayashi S, (1992). Correlation between mitochondrial enlargement in renal proximal tubules and microalbuminuria in rats with early streptozotocin-induced diabetes. Acta Pathol Jpn 42: 855-860.
119. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S, (2004). Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14: 885-890.
120. Karbowski M, Neutzner A, Youle RJ, (2007). The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178: 71-84.
121. Katyare SS, Satav JG, (2005). Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria. A comparative study of early and late effects. Diabetes Obes Metab 7: 555-562.
122. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP, (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115: 727-738.
123. KDOQI (2007). KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 (2 Suppl. 2): S12-154.
124. Kim SI, Na HJ, Ding Y, Wang Z, Lee SJ, Choi ME, (2012). Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-β1. J Biol Chem 287: 11677-11688.
125. Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, et al. (2011). Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 22: 902-913.
126. Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D, (2011). Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011: 908185.
127. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
128. Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R, et al. (2010). Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 177: 632-643.
129. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. (2004). The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461-465.
130. Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, et al. (2012). PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating serine 65. Open Biol 2: 120080.
131. Korner A, Eklof AC, Celsi G, Aperia A, (1994). Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633.
132. Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC, (2009). Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 33: 517-527.
133. Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, et al. (2013). Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxid Redox Signal [Epub ahead of print].
134. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA, (2002). Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 99: 12825-12830.
135. Kubli DA, Gustafsson AB, (2012). Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111: 1208-1221.
136. Kubli DA, Ycaza JE, Gustafsson AB, (2007). Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 405: 407-415.
137. Kubli DA, Quinsay MN, Huang C, Lee Y, Gustafsson AB, (2008). Bnip3 functions as a mitochondrial sensor of oxidative stress during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 295: H2025-H2031.
138. Lachaud V, Bidet M, Coupry I, Podevin RA, Poujeol P, Parini A, (1989). [Interaction of rilmenidine with renal imidazoline-guanidine sites]. Arch Mal Coeur Vaiss 82 (Spec No 5): 15-18.
139. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. (2012). Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335: 1638-1643.
140. Landes T, Emorine LJ, Courilleau D, Rojo M, Belenguer P, Arnaune-Pelloquin L, (2010). The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep 11: 459-465.
141. Lazarou M, Jin SM, Kane LA, Youle RJ, (2012). Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell 22: 320-333.
142. Lazarou M, Narendra DP, Jin SM, Tekle E, Banerjee S, Youle RJ, (2013). PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. J Cell Biol 200: 163-172.
143. Lee DY, Wauquier F, Eid AA, Roman LJ, Ghosh-Choudhury G, Khazim K, et al. (2013). Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J Biol Chem 288: 28668-28686.
144. Lee JY, Nagano Y, Taylor JP, Lim KL, Yao TP, (2010). Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol 189: 671-679.
145. Lee SJ, Choi MG, Kim DS, Kim TW, (2006). Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism 55: 1-7.
146. Lee Y, Lee HY, Hanna RA, Gustafsson AB, (2011). Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol 301: H1924-H1931.
147. Lemasters JJ, (2005). Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8: 3-5.
148. Lempiainen J, Finckenberg P, Mervaala E, Sankari S, Levijoki J, Mervaala E, (2013). Caloric restriction ameliorates kidney ischemia reperfusion injury through PGC-1α-eNOS-pathway and enhanced autophagy. Acta Physiol (Oxf) 208: 410-421.
149. Lezi E, Swerdlow RH, (2012). Mitochondria in neurodegeneration. Adv Exp Med Biol 942: 269-286.
150. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, et al. (2008). Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 3: e1487.
151. Li Y, Wan OW, Xie W, Chung KK, (2011). p32 regulates mitochondrial morphology and dynamics through parkin. Neuroscience 199: 346-358.
152. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, et al. (1998). Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72: 8586-8596.
153. Lim KL, Dawson VL, Dawson TM, (2006). Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol Aging 27: 524-529.
154. Liu L, Zheng T, Wang N, Wang F, Li M, Jiang J, et al. (2009). The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem 322: 87-91.
155. Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, et al. (2012). Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol 14: 177-185.
156. Liu S, Hartleben B, Kretz O, Wiech T, Igarashi P, Mizushima N, et al. (2012). Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy 8: 826-837.
157. Liu Y, (2006). Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217.
158. Liu Y, (2011). Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696.
159. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, et al. (2006). Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 17: 1395-1404.
160. Lokireddy S, Wijesoma IW, Teng S, Bonala S, Gluckman PD, McFarlane C, et al. (2012). The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 16: 613-624.
161. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lammermann K, et al. (2009). Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284: 22938-22951.
162. Ma T, Zhu J, Chen X, Zha D, Singhal PC, Ding G, (2013). High glucose induces autophagy in podocytes. Exp Cell Res 319: 779-789.
163. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, et al. (2007). Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 26: 2527-2539.
164. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al. (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471.
165. Marino G, Uria JA, Puente XS, Quesada V, Bordallo J, Lopez-Otin C, (2003). Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem 278: 3671-3678.
166. Martinou JC, Youle RJ, (2011). Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101.
167. el-Masry TM, Zahra MA, el-Tawil MM, Khalifa RA, (2005). Manganese superoxide dismutase alanine to valine polymorphism and risk of neuropathy and nephropathy in Egyptian type 1 diabetic patients. Rev Diabet Stud 2: 70-74.
168. Mather A, Pollock C, (2011). Glucose handling by the kidney. Kidney Int Suppl 120: S1-S6.
169. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, et al. (2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189: 211-221.
170. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
171. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, et al. (2009). Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361: 40-51.
172. Mauer SM, Steffes MW, Brown DM, (1981). The kidney in diabetes. Am J Med 70: 603-612.
173. Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK, (2011). The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem 117: 856-867.
174. Mellors A, Tappel AL, (1966a). The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem 241: 4353-4356.
175. Mellors A, Tappel AL, (1966b). Quinones and quinols as inhibitors of lipid peroxidation. Lipids 1: 282-284.
176. Messner B, Ploner C, Laufer G, Bernhard D, (2012). Cadmium activates a programmed, lysosomal membrane permeabilization-dependent necrosis pathway. Toxicol Lett 212: 268-275.
177. Meyer H, Bug M, Bremer S, (2012). Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol 14: 117-123.
178. Michels J, Kepp O, Senovilla L, Lissa D, Castedo M, Kroemer G, et al. (2013). Functions of BCL-X L at the interface between cell death and metabolism. Int J Cell Biol 2013: 705294.
179. Miyata T, de Strihou C, (2010). Diabetic nephropathy: a disorder of oxygen metabolism? Nat Rev Nephrol 6: 83-95.
180. Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, Felsen D, (2008). A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol 295: F1545-F1553.
181. Mollsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, et al. (2007). A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 56: 265-269.
182. Mollsten A, Jorsal A, Lajer M, Vionnet N, Tarnow L, (2009). The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes. Diabetologia 52: 2590-2593.
183. Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, Mizuno Y, et al. (2005). Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14: 71-84.
184. Morath C, Arns W, Schwenger V, Mehrabi A, Fonouni H, Schmidt J, et al. (2007). Sirolimus in renal transplantation. Nephrol Dial Transplant 22 (Suppl. 8): viii61-viii65.
185. Moreira PI, Rolo AP, Sena C, Seica R, Oliveira CR, Santos MS, (2006). Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med Chem 2: 299-308.
186. Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, et al. (2009). The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 384: 471-475.
187. Moruno F, Perez-Jimenez E, Knecht E, (2012). Regulation of autophagy by glucose in mammalian cells. Cells 1: 372-395.
188. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J, et al. (2007). Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 27: 4844-4862.
189. Mukhopadhyay P, Horvath B, Zsengeller Z, Zielonka J, Tanchian G, Holovac E, et al. (2012). Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 52: 497-506.
190. Munusamy S, MacMillan-Crow LA, (2009). Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free Radic Biol Med 46: 1149-1157.
191. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, et al. (1999). Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834.
192. Murphy M, Docherty NG, Griffin B, Howlin J, McArdle E, McMahon R, et al. (2008). IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis. J Am Soc Nephrol 19: 1672-1680.
193. Murphy M, Hickey F, Godson C, (2013). IHG-1 amplifies TGF-β1 signalling and mitochondrial biogenesis and is increased in diabetic kidney disease. Curr Opin Nephrol Hypertens 22: 77-84.
194. Murphy MP, (2009). How mitochondria produce reactive oxygen species. Biochem J 417: 1-13.
195. Murphy MP, Smith RA, (2007). Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47: 629-656.
196. Naik E, Dixit VM, (2011). Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208: 417-420.
197. Naito T, Kuma A, Mizushima N, (2013). Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle. J Biol Chem 288: 21074-21081.
198. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. (2005). Cyclophilin d-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652-658.
199. Narendra D, Tanaka A, Suen DF, Youle RJ, (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803.
200. Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ, (2010a). p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6: 1090-1106.
201. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. (2010b). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298.
202. Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, et al. (2009). Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 169: 1307-1316.
203. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. (2009). Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20: 1813-1821.
204. Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. (2003). The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 48: 138-141.
205. Norman JM, Cohen GM, Bampton ET, (2010). The in vitro cleavage of the hAtg proteins by cell death proteases. Autophagy 6: 1042-1056.
206. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Rozenknop A, et al. (2010). Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 11: 45-51.
207. Oberstein A, Jeffrey PD, Shi Y, (2007). Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282: 13123-13132.
208. Okatsu K, Saisho K, Shimanuki M, Nakada K, Shitara H, Sou YS, et al. (2010). p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells 15: 887-900.
209. Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA, Palmiter RD, et al. (2007). Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178: 1025-1038.
210. Oppenheim RW, Blomgren K, Ethell DW, Koike M, Komatsu M, Prevette D, et al. (2008). Developing postmitotic mammalian neurons in vivo lacking Apaf-1 undergo programmed cell death by a caspase-independent, nonapoptotic pathway involving autophagy. J Neurosci 28: 1490-1497.
211. Palm F, Nordquist L, (2011). Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301: R1229-R1241.
212. Palm F, Friederich M, Carlsson PO, Hansell P, Teerlink T, Liss P, (2008). Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability. Am J Physiol Renal Physiol 294: F30-F37.
213. Parajuli N, MacMillan-Crow LA, (2013). Role of reduced manganese superoxide dismutase in ischemia-reperfusion injury: a possible trigger for autophagy and mitochondrial biogenesis? Am J Physiol Renal Physiol 304: F257-F267.
214. Park YY, Lee S, Karbowski M, Neutzner A, Youle RJ, Cho H, (2010). Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci 123 (Pt 4): 619-626.
215. Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR, (1981). A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457-461.
216. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, et al. (1992). Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41: 758-762.
217. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG, (2006). Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 69: 2057-2063.
218. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939.
219. Paula-Gomes S, Goncalves DA, Baviera AM, Zanon NM, Navegantes LC, Kettelhut IC, (2013). Insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes through AKT/FOXO signaling. Horm Metab Res 45: 849-855.
220. Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin XM, Dong Z, (2008). Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 74: 631-640.
221. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS, (2003). Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293.
222. Persson MF, Franzen S, Catrina SB, Dallner G, Hansell P, Brismar K, et al. (2012). Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 55: 1535-1543.
223. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ, (2008). The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 105: 1638-1643.
224. Qi Y, Tian X, Liu J, Han Y, Graham AM, Simon MC, et al. (2012). Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis. J Cell Biol 198: 103-114.
225. Quinsay MN, Lee Y, Rikka S, Sayen MR, Molkentin JD, Gottlieb RA, et al. (2010). Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. J Mol Cell Cardiol 48: 1146-1156.
226. Radoshevich L, Murrow L, Chen N, Fernandez E, Roy S, Fung C, et al. (2010). ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell 142: 590-600.
227. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, et al. (2011). Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS ONE 6: e16746.
228. Rana A, Rera M, Walker DW, (2013). Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan. Proc Natl Acad Sci U S A 110: 8638-8643.
229. Raparia K, Usman I, Kanwar YS, (2013). Renal morphologic lesions reminiscent of diabetic nephropathy. Arch Pathol Lab Med 137: 351-359.
230. Rask-Madsen C, King GL, (2013). Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17: 20-33.
231. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, et al. (2000). BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275: 1439-1448.
232. Raza H, Prabu SK, Robin MA, Avadhani NG, (2004). Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 53: 185-194.
233. Reid JL, (2000). Rilmenidine: a clinical overview. Am J Hypertens 13 (6 Pt 2): 106S-111S.
234. Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC, (2010). Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285: 11061-11067.
235. Renna M, Bento CF, Fleming A, Menzies FM, Siddiqi FH, Ravikumar B, et al. (2013). IGF-1 receptor antagonism inhibits autophagy. Hum Mol Genet 22: 4528-4544.
236. Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN, et al. (2011). Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ 18: 721-731.
237. Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, Szweda LI, et al. (2005). Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 289: F420-F430.
238. Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S, Sadiq O, et al. (2010). Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet 19: 2144-2153.
239. Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, Turk D, Vasiljeva O, Stefe I, et al. (2003). Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ 10: 881-888.
240. Rubinstein AD, Eisenstein M, Ber Y, Bialik S, Kimchi A, (2011). The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 44: 698-709.
241. Rubinsztein DC, Codogno P, Levine B, (2012). Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11: 709-730.
242. Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A, (2006). Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 340: 296-301.
243. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, Ahmad R, et al. (2009). Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 4: e5701.
244. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M, et al. (2008). Essential role for Nix in autophagic maturation of erythroid cells. Nature 454: 232-235.
245. 2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A 105: 20728-20733.
246. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, et al. (2013). Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496: 372-376.
247. Scherz-Shouval R, Elazar Z, (2011). Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36: 30-38.
248. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z, (2007). Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760.
249. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW, (2004). Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24: 8055-8068.
250. Seigneurin-Berny D, Verdel A, Curtet S, Lemercier C, Garin J, Rousseaux S, et al. (2001). Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol 21: 8035-8044.
251. Shaid S, Brandts CH, Serve H, Dikic I, (2013). Ubiquitination and selective autophagy. Cell Death Differ 20: 21-30.
252. Sharfuddin AA, Molitoris BA, (2011). Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189-200.
253. Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, et al. (2013). Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 24: 1901-1912.
254. Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, et al. (2012). PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep 2: 1002.
255. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y, (1996). Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226: 561-565.
256. Singh DK, Winocour P, Farrington K, (2011). Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7: 176-184.
257. Sivitz WI, Yorek MA, (2010). Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12: 537-577.
258. Smith MA, Covington MD, Schnellmann RG, (2012a). Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia. Arch Biochem Biophys 523: 161-168.
259. Smith RA, Hartley RC, Cocheme HM, Murphy MP, (2012b). Mitochondrial pharmacology. Trends Pharmacol Sci 33: 341-352.
260. Soltoff SP, (1986). ATP and the regulation of renal cell function. Annu Rev Physiol 48: 9-31.
261. Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, et al. (2012). Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 52: 716-723.
262. Steinke JM, (2009). The natural progression of kidney injury in young type 1 diabetic patients. Curr Diab Rep 9: 473-479.
263. Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG, (2009). Mitochondrial accumulation of polyubiquitinated proteins and differential regulation of apoptosis by polyubiquitination sites Lys-48 and -63. J Cell Mol Med 13 (8B): 1632-1643.
264. Sun L, Xie P, Wada J, Kashihara N, Liu FY, Zhao Y, et al. (2008). Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction. J Am Soc Nephrol 19: 2293-2301.
265. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F, (2003). The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13: 145-157.
266. Szeto HH, (2008). Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 10: 601-619.
267. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, et al. (2011). Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22: 1041-1052.
268. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H, (2004). DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218.
269. Tait SW, Green DR, (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632.
270. Takahashi A, Kimura T, Takabatake Y, Namba T, Kaimori J, Kitamura H, et al. (2012). Autophagy guards against cisplatin-induced acute kidney injury. Am J Pathol 180: 517-525.
271. Takebayashi S, Kaneda K, (1991). Mitochondrial derangement: possible initiator of microalbuminuria in NIDDM. J Diabet Complications 5: 104-106.
272. Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, et al. (2010). Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol 298: F763-F770.
273. Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, et al. (2008). Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17: 431-439.
274. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, et al. (2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191: 1367-1380.
275. Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC, (2005). Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney Int 68: 391-398.
276. Teutonico A, Schena PF, Di Paolo S, (2005). Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16: 3128-3135.
277. Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M, Sandebring A, et al. (2011). DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20: 40-50.
278. Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH, (2006). The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 185: 140-144.
279. Troncoso R, Vicencio JM, Parra V, Nemchenko A, Kawashima Y, Del Campo A, et al. (2012). Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc Res 93: 320-329.
280. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. (2008). Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446.
281. Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C, (1982). Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta 710: 197-211.
282. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, et al. (1999). Dual function of the selenoprotein PHGPx during sperm maturation. Science 285: 1393-1396.
283. Vallon V, (2011). The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 300: R1009-R1022.
284. Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, et al. (2013). Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol 304: F156-F167.
285. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, et al. (2000). BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468.
286. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Muller F, (2003). Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426: 620.
287. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, et al. (2010). PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107: 378-383.
288. Wallace DC, (2012). Mitochondria and cancer. Nat Rev Cancer 12: 685-698.
289. Wang W, Wang Y, Long J, Wang J, Haudek SB, Overbeek P, et al. (2012). Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 15: 186-200.
290. 2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 136: 163-174.
291. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, et al. (2011). PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147: 893-906.
292. Wang Z, Choi ME, (2013). Autophagy in kidney health and disease. Antioxid Redox Signal [Epub ahead of print].
293. Weisiger RA, Fridovich I, (1973). Mitochondrial superoxide simutase. Site of synthesis and intramitochondrial localization. J Biol Chem 248: 4793-4796.
294. Whelan RS, Konstantinidis K, Wei AC, Chen Y, Reyna DE, Jha S, et al. (2012). Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci U S A 109: 6566-6571.
295. Whiting DR, Guariguata L, Weil C, Shaw J, (2011). IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
296. Whitman IR, Feldman HI, Deo R, (2012). CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol 23: 1929-1939.
297. Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, et al. (2010). Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 1: e18.
298. Wu WH, Zhang MP, Zhang F, Liu F, Hu ZX, Hu QD, et al. (2011). The role of programmed cell death in streptozotocin-induced early diabetic nephropathy. J Endocrinol Invest 34: e296-e301.
299. Xu Y, Yang S, Huang J, Ruan S, Zheng Z, Lin J, (2012). Tgf-β1 induces autophagy and promotes apoptosis in renal tubular epithelial cells. Int J Mol Med 29: 781-790.
300. Xu Y, Ruan S, Wu X, Chen H, Zheng K, Fu B, (2013). Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress. Int J Mol Med 31: 628-636.
301. Yadav A, Vallabu S, Arora S, Tandon P, Slahan D, Teichberg S, et al. (2010). ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol 299: C488-C496.
302. Yang C, Kaushal V, Shah SV, Kaushal GP, (2008). Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol 294: F777-F787.
303. Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, et al. (2007). Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 27: 495-502.
304. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, et al. (2008). Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 105: 7070-7075.
305. Yang Z, Klionsky DJ, (2010a). Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822.
306. Yang Z, Klionsky DJ, (2010b). Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22: 124-131.
307. Yin X, Cao L, Kang R, Yang M, Wang Z, Peng Y, et al. (2011). UV irradiation resistance-associated gene suppresses apoptosis by interfering with BAX activation. EMBO Rep 12: 727-734.
308. Youle RJ, van der Bliek AM, (2012). Mitochondrial fission, fusion, and stress. Science 337: 1062-1065.
309. Youle RJ, Strasser A, (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
310. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, et al. (2006). Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8: 1124-1132.
311. Zhan M, Brooks C, Liu F, Sun L, Dong Z, (2013). Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83: 568-581.
312. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, et al. (2005). Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14: 2063-2073.
313. Zhang L, Li L, Liu H, Borowitz JL, Isom GE, (2009). BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J 23: 3405-3414.
314. 2+ levels. J Pharmacol Exp Ther 332: 97-105.
315. Zhang Q, Wu J, Wu R, Ma J, Du G, Jiao R, et al. (2012). DJ-1 promotes the proteasomal degradation of Fis1: implications of DJ-1 in neuronal protection. Biochem J 447: 261-269.
316. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, et al. (2007). FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483.
317. Zhou R, Yazdi AS, Menu P, Tschopp J, (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225.
318. Zhu Y, Massen S, Terenzio M, Lang V, Chen-Lindner S, Eils R, et al. (2013). Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem 288: 1099-1113.
319. Ziviani E, Tao RN, Whitworth AJ, (2010). Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci U S A 107: 5018-5023.
320. Ziyadeh FN, (2004). Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15 (Suppl. 1): S55-S57.
321. Zorov DB, Juhaszova M, Yaniv Y, Nuss HB, Wang S, Sollott SJ, (2009). Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 83: 213-225.